4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-23-021561
Chief Scientific Officer sold 2,717 shares at an average $0.50 ($1,346)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Loose Christopher R. Chief Scientific Officer | 2023-07-27 | Sale 10b5-1 | −1,373 | $0.53 | $728 | 184,994 | D: show line 1 in the form |
| Loose Christopher R. Chief Scientific Officer | 2023-07-28 | Sale 10b5-1 | −1,344 | $0.46 | $618 | 183,650 | D: show line 2 in the form |
| Open-market sales · 2,717 sh · avg $0.50 · $1,346 | |||||||
Loading xslF345X05/form4.xml…